TrialBMJ open diabetes research & care2020

Efficacy, safety and cost-effectiveness comparison between U-100 human regular insulin and rapid acting insulin when delivered by V-Go wearable insulin delivery device in type 2 diabetes.

Pablo F Mora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.